China Anti-Espionage Laws Threaten Pharma Supply Chains and Multinational Manufacture in China
New anti-espionage laws in China could make an increasingly tenuous situation for Western drug buyers even worse.
Read more...New anti-espionage laws in China could make an increasingly tenuous situation for Western drug buyers even worse.
Read more...Sounds that are lower pitched are less studied than other types. Some say it’s a health hazard. Others have doubts.
Read more...A Medicare scheme to lower costs of chronic care patients gets a thumbs down from most MDs, perhaps because it was designed for middlemen?
Read more...Why medical research is hard, and often path-dependent, which may not always be a good thing.
Read more...“Vaccine hesitancy” less pervasive than some say
Read more...Eileen Appelbaum takes a critical look at Medicare Advantage, exposing how it falls short of its cost-saving and quality-enhancing promises.
Read more...A Bird Flu round-up, mostly from an institutional perspective.
Read more...Unauthorized enrollment or plan-switching is emerging as a serious challenge for the ACA, also known as Obamacare.
Read more...How to increase development of pharmaceuticals to treat tropical diseases, which afflict millions yet are neglected?
Read more...A short look at the Democrat-aligned-press breakdown over the RFK, Jr. choice of Silicon Valley’s Nichole Shanahan as his VP.
Read more...By Brett Kelman, Correspondent, who joined KFF Health News after 15 years of beat reporting at three newspapers in the USA Today Network, and Samantha Liss, Midwest Correspondent, who is an award-winning journalist covering the business of health care for the past decade. Originally published at Kaiser Health News. In the small Appalachian city of […]
Read more...Rajiv Sethi joins the pushback against censorship, using Google’s bogus attack on one of his posts on this site as a point of departure.
Read more...Private equity is setting out to hoover up accounting practices. The sorry experience in health care says there is cause for pause.
Read more...Health industry employee objections have forced the CDC to rethink its weak guidance on aerosol transmission, but experts are not optimistic.
Read more...Physician-scientist Fred Ledley and economist William Lazonick debunk Big Pharma arguments against Medicare drug price negotiation
Read more...